The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial.
Tang LQ, Li XY, Li ZM, Liu ZG, Lin MZ, Zhou H, Yu QW, Zhou J, Zhao C, Chen ZB, Wang XC, Peng JY, Chen QY, Fang WF, Yang YP, Zhang B, Xia LP, Hu PL, Hu WH, Li YJ, Mai HQ, Cai XY.
Tang LQ, et al. Among authors: hu pl.
BMC Med. 2023 Mar 16;21(1):94. doi: 10.1186/s12916-023-02790-1.
BMC Med. 2023.
PMID: 36927541
Free PMC article.
Clinical Trial.